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Summary.-2-Acetylaminofluorene induced mammary and ear duct carcinomata
and spontaneously arising mammary carcinomata and sarcomata were shown to
express embryonic antigens at the cell surface by their reaction with serum from
multiparous female rats. These observations with essentially non-immunogenic
tumours are comparable with early findings showing that embryonic antigens are
also expressed on aminoazo dye induced rat hepatomata, and sarcomata induced
with 3-methylcholanthrene. Re-expression of embryonal components, therefore,
may be a concomitant of neoplastic transformation.
THE CONCEPT that malignant cells
re-express embryonal characteristics has
gained considerable support from recent
studies showing that experimental animal
tumours induced by oncogenic viruses or
chemical carcinogens exhibit tumour asso-
ciated embryonic antigens (Alexander,
1972; Baldwin, 1973). The appearance
of so-called " oncofoetal " antigens on
human tumours is also exemplified by
x-foetoprotein associated with hepato-
cellular carcinoma and carcinoembryonic
antioen associated with malignancies of
the gastrointestinal tract (Laurence and
Neville, 1972).
These observations suggest that re-
expression of embryonal components may
be a feature of many, if not all, malignant
cells and furthermore raises the possibility
that the tumour rejection antigens demon-
strable on experimental animal tumours
(Deichman, 1969; Pasternak, 1969; Bald-
win, 1973) may be identified as embryonic
antigens. These postulates have been
analysed comprehensively using a range
of immunogenic rat tumours including
3-methyleholanthrene (Mc) induced sarco-
mata and 4-dimethylaminoazobenzene
(DAB) induced hepotomata maintained
by transplantation in syngeneic Wistar
rats (Baldwin, Glaves and Pimm, 1971;
Baldwin et al., 1972a; Baldwin, Glaves
and Vose, 1972b; Baldwin et al., 1974a).
From these studies it was concluded
that embryonic antigen expression was
a concomitant of malignant change, al-
though it was possible to differentiate
between these antigens and the tumour
rejection antigens by their specificities
(Baldwin et al., 1972, 1974a; Baldwin,
Glaves and Vose, 1974b).
All of the tumours employed in the
previous studies have been immunogenic,
as defined by their capacity to elicit
tumour rejection responses in syngeneic
hosts. Other tumours, such as mammary
carcinomata induced by 2-acetylamino-
fluorene (AAF) or arising spontaneously
within the breeding population and also
spontaneously developing sarcomata, are
generally deficient or demonstrably lack-
ing in tumour rejection antigens (Baldwin
and Embleton, 1969a, b; 1971; 1974).
These, therefore, have been examined for
tumour associated embryonic antigen to
determine further whether this expression
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is a constant feature of malignant change
and also whether these antigens are
related to the tumour rejection antigens.
MATERIALS AND METHODS
Tumours -The tumours studied included
mammary carcinomata and one ear duct
carcinoma induced in female rats fed con-
tinuously on a diet containing 0.04%o w/w
2-acetylaminofluorene (Baldwin and Emble-
ton, 1969a). Spontaneously arising mam-
mary carcinomata and sarcomata developed
in breeding female rats between 179 and
565 days of age (Baldwin and Embleton,
1969b). Tumours were passaged in syn-
geneic Wistar rats of the same sex as the
primary host and early transplant genera-
tions were preserved in liquid nitrogen
vapour. Their immunogenicity was deter-
mined by the tumour rejection response
elicited in rats immunized by implantation
of irradiated tumour grafts or by surgical
excision of growing tumour against a chal-
lenge inoculum just sufficient to produce
consistent tumour growth in controls. These
characteristics have been published pre-
viously (Baldwin and Embleton, 1969a, b;
1971; 1974) and can be summarized as
Mammiary carcinoma: AAF 20 no signifi-
cant resistance against challenge with 5 x104
tumour cells; AAF 56-no protection to
challenge with 5 x 104 tumour cells; AAF
57-no protection to challenge with 103
tumour cells; Spl1-no protection to chal-
lenge with 102 tumour cells; Sp15-re-
sistance induced to challenge with 103 but
not 104 tumour cells. Ear duct carcinoma:
AAF 49-no resistance to challenge with
5 x 104 tumour cells. Sarcoma: Sp7-no
resistance to challenge with 105 tumour cells;
Sp24 resistance to 103 but not 104 tumour
cells.
Serum donors.-Serum was taken from
rats having had more than 4 pregnancies
and which were pregnant at the time of
assay. Virgin female rats were used for
controls and were generally age matched.
Tissue cultures-.Cell culture lines were
initiated from single cell suspensions of
trypsinized transplanted tumours and main-
tained by serial subculture in Waymouth's
medium supplemented with 2000 foetal calf
serum and antibiotics. They were used as
a source of target cells for microcytotoxicity
tests between the first and sixth passage.
Microcytotoxicity tests.-The complement
dependent cytotoxicity of multiparous rat
sera for plated target cells was assayed in
Falcon Microtest plates (3034) as previously
described (Baldwin et al., 1972b). The per-
centage cytotoxicity was calculated from the
numbers of cells present in wells treated
with test serum compared with those sur-
viving in wells treated with control virgin
rat serum.
Membrane immunofluorescence tests.-The
indirect membrane immunofluorescence test
was performed on viable tumour cells in
suspension as previously described (Baldwin
and Barker, 1967). Fluorescence indices
(FI) were calculated from the proportion of
unstained cells in samples exposed to virgin
control sera compared with the proportion
of unstained cells in samples exposed to
test serum. A value of 0 30 or greater is
taken to represent a significant reaction.
RESULTS
Microcytotoxicity tests
Embryonic antigens were detected at
the surface of AAF induced mammary
and ear duct carcinomata by the com-
plement dependent cytotoxicity of sera
from multiparous rats compared with
that of virgin control sera (Table I).
All 4 tumours showed some significant
reactivity with the sera, although the
cytotoxicity was variable and generally
low compared with that previously ob-
tained with DAB induced hepatomata
and Mc induced sarcomata (Baldwin et
al., 1972b). None of the sera used could
be shown to have any reactivity against
cells from adult liver, lung, diaphragm
or kidney. Table II summarizes tests
with a larger panel of multiparous rat
sera against AAF induced tumours.
Similar tests with spontaneously aris-
ing sarcomata and mammary carcinomata
showed comparable results (Table III).
Again the percentage cytotoxicity was
generally low but significant when demon-
strable and only a low proportion of the
multiparous rat sera showed reactivity.
Table IV summarizes tests with a larger
panel of multiparous rat sera against
these tumours. None of the sera used
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TABLE I. Cytotoxicity of Multiparous Rat Serafor 2-Acetylaminoftuorene
Induced Rat Tumours
Multiparous
serum No.
Mammary carcinoma AAF20
4887
4906
4907
4914
4929
5039
Ear duict carcinoma AAF49
4832
5039
5229
4888
Mammary carcinioma AAF56
4832
4887
4906
4907
4928
4941
Mammary carcinoma AAF57
4556
4571
4577
4582
4586
4590
No. of cells* surviving
after treatment with:
A & > Percentage cell
Test serum Control serum reduction
52± 2
78-4-2
69±4
98±4
85 ± 4
75 -' 4
70± 6
70 -i-- 9
46-4
47 f 3
37- 4
42±5
52 2
61 ± 3
31 ± 3
39-z:2
157 7
210-- 6
152-6
170 7
175 + 3
187 7
95±4
66±5
66±5
95±4
95±4
95±4
75 -4
75±4
75± 4
752f4
46±7
46±7
62-4-2
62 ± 2
46- 7
62 2
179± 9
179± 9
174± 8
174 8
179± 9
174-- 8
45
-18
-5
7
11
22
7
7
39
38
20
8
16
1
333
36
1:3
17
13
2
2
-8
* AIean 4 S.E.
had any reactivity against cultured cells
derived from adult normal tissues. In
tests with both AAF induced and spon-
taneously arising rat tumours although
the cytotoxicity when significant was
..- ; +- a A .1 -d lUW, 10 was re
with serum 51
TABLE II. CT
Sera for 2-a
Rat Tumour,
Positive
reactions*
Percentage cell
recductions
Negative
reactions
Percentage cell
redluctions
cinoma AAF20 percentage cytotoxicities
obtained in separate tests were 22%,
20%, 28%, 25%.
Im mnunofluorescence tests
1prouucimue so tnat in tests Indirect membrane immunofluores-
039 against mammary car- cence tests were performed using sera
from multiparous rats against 2 AAF
ytotoxicity ofMultiparous Rat induced (AAF20 and AAF56) and 2
,cetylaminoftuorene Induced spontaneously arising mammary carcino-
s:Summary Table mata (Spl5 and Spll). In no case was
Cytotoxic reaction with cells of: a significant reaction demonstrable against
Earductany of these tumours, the maximum
carcinoma carcinoma fluorescence index obtained being 0416. --- In contrast, these sera showed a signifi- AAF 20 AAF 56 AAF 57 AAF 49 cant level of membrane staining against
9 5 ;> DAB induced hepatomata and Mc induced
sarcomata, producing fluorescence indices
11-61 16-64 13, 13 38,:39 of up to 0-86.
3 7 16 2
0-7 7, 7 0-23 7, 7
P < 0 025-0-0005.
DISCUSSION
These studies demonstrate that AAF
induced and spontaneously arising tu-
0 0005
0-10
0-025
0 0005
0-25
0 30
0*0005
0 0005
0*10
0 35
0 0025
0 45
0 025
0 0005
0 025
0 025
0(35
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TABLE III.-Cytotoxicity of Multiparous Rat Sera for Spontaneously Arising Rat
Multiparous serum No.
Sarcoma Sp7
4394
4395
4498
4499
4558
4707
Sarcoma Sp24
4363
4416
4577
4582
Mammary carcinoma Spi5
4296
4331
4400
4451
Mammary carcinoma Sp 1
4121
4362
4397
4462
Tumours
No. of cells* surviving
after treatment with:
t
A 5 Percentage
Test serum Control serum cell reduction
137± 11
141± 9
100± 7
116± 8
132± 10
116± 7
145± 17
102± 13
83±4
86± 5
90+
107±
111±
81±
141± 6
141± 6
144±11
144±11
141± 6
144±11
146± 14
146±14
84± 4
113± 6
115± 6
115± 6
115± 6
115± 6
32± 3
32± 3
32± 3
32± 3
7
6
5
4
35± 4
18± 3
40± 1
32± 5
3
0
30
19
7
20
1
30
2
24
22
7
3
30
-8
45
-26
0
0*40
0*025
0*025
0-25
0-025
0*49
0*005
0.4
0 0025
0 005
0-2
0 3
0*0005
0*0025
* Mean ± S.E.
TABLE IV.-Cytotoxicity of Multiparous
Rat Sera for Spontaneously Arising Rat
Positive
reactions*
Percentage cell
reductions
Negative
reactions
Percentage cell
reductions
*P< 0*025-0*00
mours express
cell surface
complement (
tions with ai
multiparous re
of multiparou,
or non-immun
ally lower, ho
tion of sera rec
indices than that obtained with more
immunogenic rat tumours such as DAB
ummaryTable induced hepatomata and Mc induced
Cytotoxic reaction with cells of: sarcomata (Baldwin et al., 1972a, b; A____________ 51974a). This may account for the failure
Mammary to detect embryonic antigens on AAF
Sarcoma carcinoma ** Sarcoma carcinoma induced and spontaneous tumours by
Sp7 Sp24 Spll Spl5 the membrane immunofluorescence tech-
nique which has previously been employed
4 4 1 2 for typing embryonic antigens on rat
14-30 13-30 45 22-30 hepatomata (Baldwin et al., 1972a; 1974a).
Embryonic antigens have also been
10 12 4 2 detected upon Mc induced rat sarcomata
0 0-14 0 3-7 by delayed hypersensitivity reactions
(Wang, 1968) and by serological methods
)05 using xenogeneic antisera raised against
tumour and early embryo tissues (Thom-
embryonic antigens at the son and Alexander, 1973). Sarcomata
,vhich can be detected by induced by polycyclic hydrocarbons in
dependent cytotoxic reac- mice and guinea-pigs also express em-
,ntibody in the serum of bryonic antigens demonstrable by tumour
ats. The level of reactivity rejection tests (Le Mevel and Wells,
s rat sera with these weakly 1973; Grant, Radisch and Wells, 1974)
iogenic tumours was gener- or in vitro assays of cell mediated and
iwever, both in the propor- humoral immune responses (Menard, Cal-
acting and in their cytotoxic naghi and Della Porta, 1973; Burdick
Tumours:S
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and Wells, 1973). Although a much
broader spectrum of tumours needs to
be evaluated, there is already substantial
evidence to suggest that embryonic anti-
gen expression may be a relatively con-
sistent feature of carcinogen transformed
cells. In this context, Embleton and
Heidelberger (personal communication)
have demonstrated embryonic antigens
on mouse cells transformed in vitro with
polycyclic hydrocarbons.
Embryonic antigens on chemically
induced tumours have generally proved
to be cross-reactive (Baldwin et al.,
1974a; Thomson and Alexander, 1973;
Menard et al., 1973). This is emphasized
further by the data reported here showing
that multiparous rat serum contains anti-
body reacting with cells of different
tumour types, including sarcomata and
mammary carcinomata. This does not
exclude the possible expression of organ
specific embryonic antigens on tumours
since these serum donors may have been
sensitized to a multiplicity of embryonic
antigens during pregnancy. This is sug-
gested by other studies (Baldwin and
Embleton, 1974) where lymph node cells
taken from rats bearing the essentially
non-immunogenic mammary carcinomata
employed in the present investigation
were found to be cytotoxic in vitro for
the autochthonous tumour and also other
mammary carcinomata, but not histo-
logically different tumour types. The
neoantigens involved in these responses
were viewed as being embryonic antigens
since lymph node cell cytotoxicity could
be blocked by treating target cells with
multiparous rat serum. This, however,
requires more direct evaluation since
these conclusions are relevant to immuno-
logical studies of human malignant tissue
where organ specific neoantigens have
been identified (Hellstr6m and Hellstrom,
1973).
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